Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
4000 outpatients or hospitalized patients with coronary heart diseasewill be enrolled in this study.
18 years of age or older;
the most recent symptoms of coronary heart disease within 7 days;
meet one of the following conditions: A. clinical history of typical ischemic chest pain (more than 5 minutes of persistent chest pain); B. serum cardiac biomarkers positive (TnT/I or creatine kinase peak greater than 99% of URL); C. Electrocardiogram changes of myocardial ischemia.
pregnant women or plan to;
participate in any drug clinical trials within 3 months;
patients with life-threatening complications, or the researchers determined that the survival time of patients with no more than 1 years;